Charlie Hatton

14PUBLICATIONS
159CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsBiologically active moleculesSupramolecular chemistryHaematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 08, 2026
CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trials.

|Feb 16, 2026
High-throughput ligand diversification to discover chemical inducers of proximity.

James B Shaum, Miquel Muñoz I Ordoño, Erica A Steen

|Sep 15, 2025
High-throughput diversification of protein-ligand surfaces to discover chemical inducers of proximity.

James B Shaum, Miquel Muñoz I Ordoño, Erica A Steen

|Sep 01, 2025
p300/CBP is an essential driver of pathogenic enhancer activity and gene expression in Ewing sarcoma.

Laura C Godfrey, Brandon Regalado, Sydney R Schweber

|Jun 19, 2025
KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98-Rearranged Acute Myeloid Leukemia.

Nicole L Michmerhuizen, Emily B Heikamp, Ilaria Iacobucci

|Dec 14, 2023
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML.

Wallace Bourgeois, Jevon A Cutler, Brandon J Aubrey

Pageof 3

Frequent Collaborators

11 joint publications

Scott A Armstrong

6 joint publications

Daniela V Wenge

4 joint publications

Eric S Fischer

4 joint publications

Yana Pikman